Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

Conditions:   Gastric Adenocarcinoma;   Pancreatic Cancer;   Gastroesophageal Junction Adenocarcinoma Intervention:   Drug: CT041 autologous CAR T-cell injection Sponsors:   Carsgen Therapeutics, Ltd.;   Beijing Cancer Hospital;   Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials